# Cytek Biosciences, Inc. (CTKB): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Cytek Biosciences, Inc. (CTKB) is 45/100, ranked against 24,000+ stocks in 35 markets (Quality 39, Value 34, Momentum 64, each scored against its sector).

- StockRank: 45/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 39, Value 34, Momentum 64: each a 0-100 percentile within Healthcare.
- Position: #14,693 overall, #1,296 in Healthcare.
- Listing: United States, NMS; Healthcare / Medical Devices.
- Last close: 5.59 USD on 23 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.
- Buybacks, last 180 days: the company bought back USD 15.1M on 2 days.

Source: https://moatmap.ai/stock/CTKB
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker